Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

NCT00191841

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Barnaul, Russia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Moscow, Russia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saint Petersburg, Russia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ufa, Russia
View Trial Details
Completed

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

NCT00042679

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
Locations
  • Bakersfield, California, United States
  • Berkeley, California, United States
  • Torrance, California, United States
  • Miami Beach, Florida, United States
View Trial Details
Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

NCT00034268

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Hot Springs, Arkansas, United States
  • Springdale, Arkansas, United States
  • Los Angeles, California, United States
  • Santa Rosa, California, United States
View all 105 locations
View Trial Details
Completed

Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer

NCT00073385

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Wilshire Oncology Medical Group La Verne, California, United States
  • Hematology and Oncology Specialists, LLC New Orleans, Louisiana, United States
  • HemOnCare Brooklyn, New York, United States
  • Montefiore Medical Center, Department of Oncology The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

NCT06732401

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Cancer - Tarzana Tarzana, California, United States
View all 193 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

NCT06305754

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Kaiser Permanente - Oakland ( Site 0054) Oakland, California, United States
  • Kaiser Permanente - Roseville ( Site 0055) Roseville, California, United States
  • Kaiser Permanente - San Francisco ( Site 0056) San Francisco, California, United States
  • Kaiser Permanente - Santa Clara ( Site 0057) Santa Clara, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

NCT06120140

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • City of Hope Duarte, California, United States
  • Providence Fullerton Fullerton, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
View all 93 locations
View Trial Details

Related conditions